Ocean Biomedical, Inc. Faces Compliance Issues with Nasdaq Due to Delayed Financial Filings
Ocean Biomedical received a Nasdaq compliance notice for delayed financial report filings, impacting potential listing status.Quiver AI SummaryOcean Biomedical, Inc. announced it received a notice from...
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...
Ocean Biomedical (NASDAQ: OCEA) Receives U.S. Patent Approval Notice for New Malaria Treatment
Ocean Biomedical, Inc. (NASDAQ: OCEA) is engaged as a biopharmaceutical company, which is focused on the development and commercialization of